Targeted cytotoxic therapy kills persisting HIV infected cells during ART.
Paul W Denton, Julie M Long, Stephen W Wietgrefe et al. · PLoS Pathogens · 2014
Abstract onlyNot checked
Arts and Humanities: papers
Filters2 filters applied
Status
- No notice
- Not checked
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
8 papersQuestions on this topic
CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
Jin Fan, Hua Liang, Xiaolin Ji et al. · Nature Communications · 2019
Abstract onlyNot checked
Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
Alexander O Pasternak, Jelmer Vroom, Neeltje A Kootstra et al. · eLife · 2021
Abstract onlyNot checked
Human Immunodeficiency Virus-1 Latency Reversal via the Induction of Early Growth Response Protein 1 to Bypass Protein Kinase C Agonist-Associated Immune Activation
Lilly M. Wong, Dajiang Li, Yuyang Tang et al. · Frontiers in Microbiology · 2022
Abstract onlyNot checked
Intact provirus and integration sites analysis in acute HIV-1 infection and changes after one year of early antiviral therapy
Gabriella Rozera, Giuseppe Sberna, Giulia Berno et al. · Journal of Virus Eradication · 2022
Abstract onlyNot checked
HIV Eradication: Combinatorial Approaches to Activate Latent Viruses
Elisa De Crignis, Tokameh Mahmoudi · Viruses · 2014
Abstract onlyNot checked
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses
Trina Racine, Gary P. Kobinger, Eric J. Arts · AIDS Research and Therapy · 2017
Abstract onlyNot checked
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
Monica D. Reece, Ruby R. Taylor, Colin Song et al. · Frontiers in Immunology · 2021
Abstract onlyNot checked